R. Brigg Turner, PharmD, BCPS

Phone Number: 
503-352-7288
UC Box: 
A192

Teaching

Block coordinator

PHRM 681 | Infectious Diseases I

PHRM 682 | Infectious Diseases II

PHRM 686 | Infectious Diseases III

Teaching

PHRM 681 | Infectious Diseases I

PHRM 682 | Infectious Diseases II

PHRM 686 | Infectious Diseases III

Education

2013 | PGY-2 Infectious Diseases Pharmacy Residency, West Virginia University Healthcare, Morgantown, W.V. 

2012 | PGY-1 Pharmacy Residency, West Virginia University Healthcare, Morgantown, W.V. 

2011 | Doctor of Pharmacy, Lake Erie College of Osteopathic Medicine, Erie, Pa. 

2007 | Bachelor of Science, Neuroscience, Brigham Young University, Provo, Utah

Areas of Research & Specialization

Interest areas include infectious diseases, antimicrobial resistance, antimicrobial stewardship, and pharmacokinetics/pharmacodynamics of antimicrobials.

Clinical Practice Site

Legacy Health, Emanuel Medical Center, Portland, OR.

Publications

Turner RB, Elbarbry F, Biondo L. Pharmacokinetics of once and twice daily dosing of intravenous tobramycin in paediatric patients with cystic fibrosis. J Chemother 2015: epub ahead of print.

Turner RB, Rouse S, Elbarbry F, Wanek S, Grover V, Chang E. Azithromycin pharmacokinetics in adults with acute respiratory distress syndrome undergoing treatment with extracorporeal-membrane oxygenation. Ann Pharmacother 2015; epub ahead of print.

Turner RB, Martello JL, Malhotra A. Worsening renal function in patients with baseline renal impairment treated with intravenous voriconazole: A systematic review. Int J Antimicrob Agents 2015;46:362-366.

Turner RB, Slain D, Petros K, Keller LA, Sarwari AR. Clinical outcomes following hospital-wide implementation of prolonged-infusion cefepime and ceftazidime. Int J Antimicrob Agents 2015;46(1):129-30.

Bolus J, Turner RB. Prolonged-infusion dosing of beta-lactam antibiotics. US Pharm 2015;40(4):HS19-23.

Turner RB, Slain D. Colistin Dosing: What is the Current Approach? Making a Difference in Infectious Diseases Pharmacotherapy 2014; 4(1): 5-15.

Turner RB, Grover A, Malhotra A. The Clinical Management of Pancreatic Cancer. US Pharm 2014;39(9, Supp):8-11.

Turner RB, Smith CB, Martell JL, Slain D. Role of doxycycline in Clostridium difficile infection acquisition. Ann Pharmacother 2014; 48(6): 772-6.

Turner RB, Vagula M, Devi SS. Osteoporosis: an understated complication of diabetes. U.S. Pharmacist 2009; 34(5 supp):14-16.

Select Poster Presentations

Bath S, Turner RB, Lines J, Malhotra A, Loeffler A.  Impact of standardization of duration of antibiotic prophylaxis for prevention of surgical site infections in pediatric cardiac surgery. [podium] Interscience Conference on Antimicrobial Agents and Chemotherapy, September 2015, San Diego, CA. 

Turner RB, Valcarlos E, Won R. Impact of infectious diseases consultation and polymerase chain reaction on clinical outcomes of Staphylococcus aureus bacteremia at a community health system. [abstract S-896] Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA: September 2015.

Loeffler AM, Valcarlos E, Turner RB, Little M, Gilbert M. Antimicrobial Stewardship Pilot Project at Randall Children’s Hospital. [podium] 5th Annual International Pediatric Antimicrobial Stewardship Conference, Pediatric Infectious Diseases Society; Kansas City, MO: June 2014.

Turner RB, Cumpston A, Sweet M, Briggs F, Slain D, Wen S, Craig M, Hamadani M, Petros W. A Prospective, Controlled Study of Acyclovir Pharmacokinetics in Obese Patients [abstract A-707]. 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society of Microbiology, Washington DC: September 2014.

Turner RB, Cummiskey B, Kojiro K, Chang E, Michaels A. Vancomycin Pharmacokinetics in Adult Patients Receiving Extracorporeal Membrane Oxygenation [A-1313]. 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society of Microbiology, Washington DC: September 2014. 

Turner RB, Biondo L, Slain D, Phillips U, Cardenas S, Moffett K. A Randomized Pilot Study of Continuous Versus Intermittent Infusion Piperacillin-Tazobactam for the Treatment of Pulmonary Exacerbations in Patients with Cystic Fibrosis [abstract 332]. Annual North American Cystic Fibrosis Conference, Salt Lake City, UT: October 2013. 

Turner RB, Biondo L. Twice Daily Dosing of Tobramycin Improves Attainment of Pharmacokinetic Parameters in Pediatric Patients with Cystic Fibrosis [abstract 333]. Annual North American Cystic Fibrosis Conference, Salt Lake City, UT: October 2013.

Kirk H, Turner RB, Sweet M, LaSala PR, Slain D, Khakoo R. Comparison of Methicillin-Resistant Staphylococcus aureus Contamination Rates of Medication Cabinets Between Isolation and Non-Isolation Rooms [abstract 1690]. IDWeek 2013, San Francisco, CA: October 2013.

Turner RB, Keller L, Slain D, Petros K, Sarwari A. Prolonged Infusion of Cephalosporins Did Not Improve Outcomes in Gram-Negative Infections in the Clinical Setting [abstract K-718]. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society of Microbiology, Denver, CO: September 2013.

Office Location: 
Creighton Hall 452
Hours: 

By Appointment

Related Courses: 
Area of Study I Teach (Graduate/Professional):